Morgan Stanley’s Oculis Holding OCS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$3.12M Buy
225,083
+158,846
+240% +$3.61M ﹤0.01% 4563
2026
Q1
$1.76M Buy
66,237
+63,187
+2,072% +$1.67M ﹤0.01% 4845
2025
Q4
$60.9K Sell
3,050
-3,366
-52% -$67.3K ﹤0.01% 6371
2025
Q3
$113K Sell
6,416
-5,742
-47% -$102K ﹤0.01% 6101
2025
Q2
$236K Buy
12,158
+7,042
+138% +$129K ﹤0.01% 5791
2025
Q1
$97.4K Buy
+5,116
New +$105K ﹤0.01% 6014

Other funds holding OCS

Morgan Stanley's OCS Position: Q2 2026 in Review

Morgan Stanley increased its Oculis Holding (OCS) stake by 240% in Q2 2026, buying an estimated $3.61M and bringing the position to 225,083 shares worth $3.12M. The position accounts for ﹤0.01% of the portfolio, ranked #4563.

Morgan Stanley first reported a position in OCS in Q1 2025 and has held it in 6 quarters since. 59 funds tracked by Wall St. Rank hold OCS as of Q2 2026.

  • Morgan Stanley held 225,083 shares of Oculis Holding worth $3.12M as of Q2 2026.
  • Morgan Stanley bought 158,846 Oculis Holding shares in Q2 2026, an estimated $3.61M.
  • Oculis Holding made up ﹤0.01% of Morgan Stanley's portfolio in Q2 2026, its #4563 holding.
  • Morgan Stanley first reported a position in Oculis Holding in Q1 2025 and has held it in 6 quarters since.
  • 59 funds tracked by Wall St. Rank held Oculis Holding as of Q2 2026.

Based on Morgan Stanley's 13F filing for Q2 2026, filed 13 Aug 2026.